Oncologica has announced the launch of its new antibody allergy test, Allergyfocus, which quickly and accurately detects 99% of common global allergies.

The new Allergyfocus test helps users discover the common global allergens that their bodies react to.

It provides a comprehensive personalised antibody profile of a patient’s allergy triggers for precise diagnosis.

The molecular IgE antibody test uses a simple finger prick sample, which is self-collected at home before being returned to the company’s accredited laboratory for testing.

There, the test sample is compared with 300 allergens, which cover 99% of common global allergens, to measure the levels of IgE antibodies.

Allergyfocus provides results within three days of receiving the sample.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Oncologica co-founder and scientific director Dr Marco Loddo said: “Our allergy test is safe and uses a small volume of blood to give a diagnostic readout.

“Allergyfocus detects antibodies that are raised against a particular allergen. The antibody allergy test helps sufferers avoid the trial and elimination approach to identifying the cause of their allergic reactions and multiple visits to allergy specialists.

“The fast and accurate allergy test provides a comprehensive personalised antibody profile of allergy triggers to aid precise diagnosis and helps guide sufferers and healthcare professionals to the appropriate next steps.”

Oncologica claimed that its Allergyfocus test can also determine the involvement of the immune system.

Allergic reactions covered by the new test include proteins secreted from house dust mites, foods, pollen from trees and grasses, pets, moulds, and wasp and bee venoms.

According to the company, 20% of children and 30% of adults are estimated to develop allergies in their lifetime.

It noted that people can be allergic to dust, pollen, pet dander or certain foods that can trigger rashes, hay fever, eczema, vomiting, wheezing, stomach pains or even anaphylactic shock.

However, it is difficult to know whether the symptoms and signs are related to an allergy or another condition.